Systolic heart failure: a prothrombotic state
Research output: Contribution to journal › Journal article › Research › peer-review
Systolic heart failure is a common syndrome whose incidence is expected to increase. Several treatment modalities, such as beta-blockers and angiotensin-converting enzyme inhibitors, improve survival. Whether antithrombotic treatment is effective remains to be elucidated, although observations suggest a prothrombotic state in heart failure. This article focuses on this prothrombotic state and discusses the risk of thromboembolic events, pathophysiological mechanisms, and the potential role of anticoagulant treatment.
Original language | English |
---|---|
Journal | Seminars in Thrombosis and Hemostasis |
Volume | 35 |
Issue number | 5 |
Pages (from-to) | 497-504 |
Number of pages | 8 |
ISSN | 0094-6176 |
DOIs | |
Publication status | Published - 1 Jul 2009 |
Bibliographical note
Keywords: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Embolism; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Thromboembolism; Warfarin
ID: 20320180